Stelara ( DrugBank: - )

6 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	11
56	ベーチェット病	1
96	クローン病	122
97	潰瘍性大腸炎	22
269	化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群	1
271	強直性脊椎炎	1

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 10 of 11 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-001489-53-PT (EUCTR)	04/02/2019	08/11/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Ecuador;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Col ...
2	EUCTR2017-001489-53-PL (EUCTR)	24/09/2018	23/07/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Colombia;Hu ...
3	EUCTR2017-001489-53-BG (EUCTR)	27/06/2018	28/03/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Colombia;Hu ...
4	EUCTR2017-001489-53-HU (EUCTR)	14/06/2018	03/04/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	500	Phase 3	Portugal;United States;Serbia;Philippines;Taiwan;Ecuador;Spain;Ukraine;Lithuania;Russian Federation; ...
5	EUCTR2017-001489-53-ES (EUCTR)	12/06/2018	14/03/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	500	Phase 3	Portugal;United States;Serbia;Philippines;Taiwan;Ecuador;Spain;Ukraine;Lithuania;Russian Federation; ...
6	EUCTR2017-001489-53-DE (EUCTR)	08/05/2018	23/03/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in ...	Systemic Lupus Erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Colombia;Hu ...
7	EUCTR2017-001489-53-LT (EUCTR)	07/05/2018	19/03/2018	Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: Stelara INN or Proposed INN: ustekinumab Other descriptive name: USTEKINUMAB Trade Name: St ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	500	Phase 3	United States;Serbia;Portugal;Taiwan;Thailand;Spain;Ukraine;Lithuania;Russian Federation;Colombia;Hu ...
8	EUCTR2014-005000-19-PL (EUCTR)	22/09/2015	18/08/2015	A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study of Ustekinumab i ...	Systemic Lupus Erythematosus MedDRA version: 20.0;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: ustekinumab P ...	Janssen-Cilag International N.V.	NULL	Not Recruiting	Female: yes Male: yes	102	Phase 2	United States;Hungary;Taiwan;Mexico;Argentina;Spain;Poland;Australia;Germany
9	EUCTR2014-005000-19-DE (EUCTR)	17/06/2015	12/02/2015	A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study of Ustekinumab i ...	Systemic Lupus Erythematosus MedDRA version: 18.1;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: ustekinumab T ...	Janssen-Cilag International N.V.	NULL	Not Recruiting	Female: yes Male: yes	134	Phase 2	United States;Hungary;Taiwan;Mexico;Argentina;Poland;Spain;Australia;Germany
10	EUCTR2014-005000-19-ES (EUCTR)	11/05/2015	03/03/2015	A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus	A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study of Ustekinumab i ...	Systemic Lupus Erythematosus MedDRA version: 17.1;Level: PT;Classification code 10042945;Term: Syste ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: ustekinumab T ...	Janssen-Cilag International N.V.	NULL	Not Recruiting	Female: yes Male: yes	100	Phase 2	United States;Hungary;Taiwan;Mexico;Argentina;Poland;Spain;Australia;Germany

First Previous1 2Next Last

先頭へ

56. ベーチェット病

臨床試験数 : 81 / 薬物数 : 107 - (DrugBank : 30) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 116

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-002190-37-FR (EUCTR)	30/10/2015	12/01/2016	A Study to Evaluate the Efficacy and Safety of Ustekinumab in patients with Behçet disease	A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal An ...	Behçet diseaseSTELABEC-1: patients with oral ulcersSTELABEC-2 : patients with active posterior uveit ...	Trade Name: STELARA Product Name: STELARA INN or Proposed INN: Ustekinumab	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 2	France

First Previous1Next Last

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

diseases per page:

Showing 1 to 10 of 122 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004457-76-HU (EUCTR)	17/05/2022	10/03/2022	A Long-term Extension Study of Ustekinumab in Pediatric Participants with different medical conditio ...	A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Cl ...	Paediatric conditions in - Moderately to Severely Active Crohn's Disease - Moderately to Severely Ac ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	151	Phase 3	United States;Spain;Turkey;Russian Federation;Italy;United Kingdom;France;Hungary;Argentina;Belgium; ...
2	NCT04779762 (ClinicalTrials.gov)	January 2022	28/2/2021	Stelara and Diet Trial for Crohns Disease	Stelara and CDED Diet Trial for Crohns Disease	Crohn Disease	Other: Crohn's disease exclusion diet (CDED);Drug: Ustekinumab Injection [Stelara]	Wolfson Medical Center	Sheba Medical Center, Israel	Not yet recruiting	18 Years	65 Years	All	40	N/A	Israel
3	EUCTR2020-004527-16-IT (EUCTR)	21/12/2021	29/09/2021	A study to test whether BI 706321 combined with ustekinumab helps people with Crohn’s Disease	A Phase IIa, randomised, double-blind, placebo-controlled trial to evaluate the safety, efficacy, ph ...	Crohn`s Disease (CD) MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disea ...	Trade Name: Stelara130mg / 26mL concentrate for solution for infusion Product Name: Stelara130mg / 26 ...	BOEHRINGER INGELHEIM INTERNATIONAL GMBH	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 2	France;United States;Czechia;Spain;Poland;Belgium;Italy
4	NCT05029921 (ClinicalTrials.gov)	December 10, 2021	30/8/2021	A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's ...	A Phase 4, Single Arm, Open-Label, 52-Week, Multicenter Study to Evaluate the Safety and Efficacy of ...	Crohn Disease	Drug: Ustekinumab	Janssen Research & Development, LLC	NULL	Recruiting	18 Years	N/A	All	180	Phase 4	China
5	EUCTR2020-004457-76-PL (EUCTR)	28/10/2021	15/09/2021	A Long-term Extension Study of Ustekinumab in Pediatric Participants with different medical conditio ...	A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Cl ...	Paediatric conditions in - Moderately to Severely Active Crohn's Disease - Moderately to Severely Ac ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	United States;Spain;Turkey;Russian Federation;Italy;United Kingdom;France;Hungary;Argentina;Poland;B ...
6	EUCTR2020-002674-26-DE (EUCTR)	19/05/2021	17/11/2020	A Study to compare the efficacy of Risankizumab and Utsekinumab in Subjects with Moderately to Sever ...	A phase 3, multicenter, Randomized, Efficacy Assessor-Blinded study of Risankizumab Compared to Uste ...	Crohns Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sys ...	Product Name: Risankizumab Product Code: ABBV-066 INN or Proposed INN: RISANKIZUMAB Product Name: Risan ...	AbbVie Deutschland GmbH & Co. KG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	508	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Chile;Switzerland;Italy;France ...
7	EUCTR2018-002629-51-CZ (EUCTR)	12/05/2021	02/03/2021	A Clinical Study to Evaluate the Safety and Efficacy of Intravenous Re-induction Therapy With Usteki ...	A Phase 3b, Randomized, Double-blind, Multicenter Study to Evaluate the Safety and Efficacy of Intra ...	Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	United States;Czechia;Spain;Austria;Russian Federation;Italy;United Kingdom;France;Czech Republic;Ge ...
8	NCT04795960 (ClinicalTrials.gov)	March 18, 2021	9/3/2021	Microbiome Modification to Enhance Stelara Response in Crohn's Disease	Microbiome Modification to Enhance Stelara Response in Crohn's Disease	Crohn Disease	Dietary Supplement: Low serine diet;Dietary Supplement: High serine diet	University of Michigan	Kenneth Rainin Foundation	Recruiting	18 Years	70 Years	All	10	N/A	United States
9	EUCTR2019-004225-24-DE (EUCTR)	17/03/2021	17/11/2020	A Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Intravenous Inductio ...	A Phase 3 Study of the Efficacy, Safety, and Pharmacokinetics of Ustekinumab as Open-label Intraveno ...	Moderately to Severely Active Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Hungary;Poland;Belgium;Russian Federation;Germany;United Kingdom;Japan
10	EUCTR2020-002674-26-RO (EUCTR)	25/02/2021	25/05/2022	A Study to compare the efficacy of Risankizumab and Utsekinumab in Subjects with Moderately to Sever ...	A phase 3, multicenter, Randomized, Efficacy Assessor-Blinded study of Risankizumab Compared to Uste ...	Crohns Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sys ...	Product Name: Risankizumab Product Code: ABBV-066 INN or Proposed INN: RISANKIZUMAB Product Name: Risan ...	AbbVie Deutschland GmbH & Co. KG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	508	Phase 3	United States;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Chile;Switzerland;Italy;France ...

First Previous1 2 3 4 5…13Next Last

先頭へ

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 10 of 22 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004457-76-HU (EUCTR)	17/05/2022	10/03/2022	A Long-term Extension Study of Ustekinumab in Pediatric Participants with different medical conditio ...	A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Cl ...	Paediatric conditions in - Moderately to Severely Active Crohn's Disease - Moderately to Severely Ac ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	151	Phase 3	United States;Spain;Turkey;Russian Federation;Italy;United Kingdom;France;Hungary;Argentina;Belgium; ...
2	EUCTR2020-004457-76-PL (EUCTR)	28/10/2021	15/09/2021	A Long-term Extension Study of Ustekinumab in Pediatric Participants with different medical conditio ...	A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Cl ...	Paediatric conditions in - Moderately to Severely Active Crohn's Disease - Moderately to Severely Ac ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	180	Phase 3	United States;Spain;Turkey;Russian Federation;Italy;United Kingdom;France;Hungary;Argentina;Poland;B ...
3	EUCTR2019-004224-38-DE (EUCTR)	25/02/2021	20/10/2020	A Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Intravenous Inductio ...	A Phase 3 Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Open-label Intravenou ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	90	Phase 3	United States;Hungary;Poland;Belgium;Russian Federation;Germany;United Kingdom;Japan
4	EUCTR2019-004224-38-HU (EUCTR)	30/12/2020	22/10/2020	A Clinical Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Intravenous Inductio ...	A Phase 3 Study of the Efficacy, Safety and Pharmacokinetics of Ustekinumab as Open-label Intravenou ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Trade Name: STELARA® Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab O ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	90	Phase 3	United States;Hungary;Poland;Belgium;Russian Federation;Germany;United Kingdom;Japan
5	EUCTR2019-004652-11-SI (EUCTR)	28/08/2020	31/08/2020	A Study of Etrolizumab-Based Induction Therapy Combinations Followed by Etrolizumab Maintenance Ther ...	RANDOMIZED, OPEN-LABEL PHASE 3B STUDY OF ETROLIZUMAB BASED INDUCTION THERAPY COMBINATIONS FOLLOWED B ...	Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerativ ...	Product Name: Etrolizumab Product Code: RO5490261/F04-02 INN or Proposed INN: Etrolizumab Other descrip ...	F. Hoffmann-La Roche Ltd	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	372	Phase 3	Serbia;United States;Slovakia;Spain;Ukraine;Ireland;Israel;Russian Federation;Italy;Switzerland;Fran ...
6	EUCTR2014-005606-38-PL (EUCTR)	05/02/2016	17/11/2015	A Study to Evaluate the Safety and Efficacy of the Ustekinumab Induction and Maintenance Therapy in ...	A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Eva ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab Trade Name: STELARA® P ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	951	Phase 3	United States;Serbia;Slovakia;Austria;Russian Federation;Israel;United Kingdom;Italy;France;Czech Re ...
7	EUCTR2014-005606-38-DK (EUCTR)	02/11/2015	30/06/2015	A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Eva ...	A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Eva ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab Trade Name: STELARA® P ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	951	Phase 3	United States;Serbia;Slovakia;Austria;Russian Federation;Israel;United Kingdom;Italy;France;Czech Re ...
8	EUCTR2014-005606-38-SK (EUCTR)	22/10/2015	07/07/2015	A Study to Evaluate the Safety and Efficacy of the Ustekinumab Induction and Maintenance Therapy in ...	A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Eva ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab Trade Name: STELARA® P ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	951	Phase 3	Serbia;United States;Czechia;Slovakia;Austria;Israel;Russian Federation;United Kingdom;Italy;France; ...
9	EUCTR2014-005606-38-BG (EUCTR)	21/10/2015	03/09/2015	A Study to Evaluate the Safety and Efficacy of the Ustekinumab Induction and Maintenance Therapy in ...	A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Eva ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: Ustekinumab Trade Name: STELARA® P ...	Janssen-Cilag International NV	NULL	Not Recruiting	Female: yes Male: yes	951	Phase 3	Serbia;United States;Czechia;Slovakia;Austria;Israel;Russian Federation;United Kingdom;Italy;France; ...
10	EUCTR2014-005606-38-IT (EUCTR)	13/10/2015	22/01/2021	A Study to Evaluate the Safety and Efficacy of the Ustekinumab Inductionand Maintenance Therapy in P ...	A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group,Multicenter Protocol to Eval ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Ustekinumab Product Code: CNTO1275 INN or Proposed INN: USTEKINUMAB Trade Name: STELARA- ...	JANSSEN CILAG INTERNATIONAL NV	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	951	Phase 3	Serbia;United States;Czechia;Slovakia;Austria;Israel;Russian Federation;United Kingdom;Italy;France; ...

First Previous1 2 3Next Last

先頭へ

269. 化膿性無菌性関節炎・壊疽性膿皮症・アクネ症候群

臨床試験数 : 23 / 薬物数 : 30 - (DrugBank : 12) / 標的遺伝子数 : 15 - 標的パスウェイ数 : 106

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-002920-41-DE (EUCTR)	04/01/2012	24/08/2011	Stelara® (Ustekinumab) treatment in Patients with Pyoderma gangrenosum	Open-label Trial of Stelara® (Ustekinumab) In Patients with Pyoderma gangrenosum – an open, non-plac ...	Patients with a clinical diagnosis of Pyoderma gangrenosum MedDRA version: 14.1;Level: LLT;Classific ...	Trade Name: Stelara Product Name: Ustekinumab Other descriptive name: USTEKINUMAB	University Hospital Tübingen	NULL	Not Recruiting			Female: yes Male: yes	10	Phase 2	Germany

First Previous1Next Last

271. 強直性脊椎炎

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-000844-56-DE (EUCTR)	12/07/2011	09/06/2011	UsTekinumab for the treatment Of Patients with active Ankylosing Spondylitis	UsTekinumab for the treatment Of Patients with active Ankylosing Spondylitis (TOPAS) – a 28-week, pr ...	Ankylosing spondylitis MedDRA version: 13.1;Level: PT;Classification code 10002556;Term: Ankylosing ...	Trade Name: Stelara Product Name: Ustekinumab	Charité Universitätsmedizin Berlin	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Germany

First Previous1Next Last

先頭へ